At a glance
ClinicalIndex Comparison RecordN/ACompleted· 105 enrolled
Drug / intervention
senofilcon C +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Long-Term Evaluation of Approved and Investigational Contact Lenses
In Brief
A clinical study evaluating senofilcon C and comfilcon A for Visual Disorders. Completed, enrolled 105 participants across 6 sites.
Detailed Summary
This is a multi-site, dispensing, 4-visit, 2-arm parallel group, randomized, double-masked clinical trial using a Vistakon investigational contact lens (test) and a marketed monthly replacement contact lens (control). Each subject will be assigned randomly to either the test or control lens to evaluate the long term safety and efficacy of the investigational contact lens compared to the marketed contact lens over a period of six months of lens wear.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Disorders
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartOct 2015
First PostedDec 2015
Primary CompletionFeb 2016
TodayJul 2026
First PostedDec 9, 2015
Enrollment StartOct 1, 2015
Primary CompletionFeb 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 10.6 years ago
Interventions
senofilcon Cdevice
comfilcon Adevice